Researchers have long argued that a spinal treatment sold by Medtronic was no better than an older one and possibly more risky. Now they have the proof.
Outside review of clinical data finds a spinal treatment's benefit overstated
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You
Sponsored Content